IL142761A0 - Novel system for regulating transgene expression - Google Patents

Novel system for regulating transgene expression

Info

Publication number
IL142761A0
IL142761A0 IL14276199A IL14276199A IL142761A0 IL 142761 A0 IL142761 A0 IL 142761A0 IL 14276199 A IL14276199 A IL 14276199A IL 14276199 A IL14276199 A IL 14276199A IL 142761 A0 IL142761 A0 IL 142761A0
Authority
IL
Israel
Prior art keywords
nucleic acid
transgene expression
novel system
expression
tta
Prior art date
Application number
IL14276199A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL142761A0 publication Critical patent/IL142761A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
IL14276199A 1998-11-09 1999-11-09 Novel system for regulating transgene expression IL142761A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (fr) 1998-11-09 1998-11-09 Nouveau systeme de regulation de l'expression d'un transgene
US12260099P 1999-03-03 1999-03-03
PCT/FR1999/002752 WO2000028062A1 (fr) 1998-11-09 1999-11-09 Nouveau systeme de regulation de l'expression d'un transgene

Publications (1)

Publication Number Publication Date
IL142761A0 true IL142761A0 (en) 2002-03-10

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14276199A IL142761A0 (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Country Status (11)

Country Link
EP (1) EP1129204B1 (ja)
JP (1) JP4516215B2 (ja)
KR (1) KR20020013476A (ja)
CN (1) CN1352694A (ja)
AT (1) ATE317020T1 (ja)
AU (1) AU1165400A (ja)
CA (1) CA2351015C (ja)
DE (1) DE69929718T2 (ja)
HU (1) HUP0104032A3 (ja)
IL (1) IL142761A0 (ja)
WO (1) WO2000028062A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
WO2002086131A1 (fr) * 2001-04-09 2002-10-31 Gencom Corporation Unite de regulation de l'expression genetique et utilisation de cette unite
CN1453361A (zh) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 一种抗癌靶向可调控基因－病毒的构建方法
MX2012005340A (es) * 2009-11-05 2012-12-05 Proyecto Biomedicina Cima Sl Sistemas de expresion regulada.
CN102690338A (zh) * 2012-05-25 2012-09-26 中国农业大学 一种与四环素结合的蛋白TetR及其编码基因和应用
CN110358812B (zh) * 2019-06-25 2022-12-27 武汉生物工程学院 一种用于λ-Red重组系统基因敲除重组阳性克隆检测的引物及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165162C (en) * 1993-06-14 2000-05-23 Hermann Bujard Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
KR20020013476A (ko) 2002-02-20
CA2351015C (fr) 2011-09-27
JP4516215B2 (ja) 2010-08-04
EP1129204B1 (fr) 2006-02-01
DE69929718T2 (de) 2006-11-09
AU1165400A (en) 2000-05-29
DE69929718D1 (de) 2006-04-13
WO2000028062A1 (fr) 2000-05-18
ATE317020T1 (de) 2006-02-15
EP1129204A1 (fr) 2001-09-05
HUP0104032A2 (hu) 2002-02-28
JP2002529099A (ja) 2002-09-10
CA2351015A1 (fr) 2000-05-18
CN1352694A (zh) 2002-06-05
HUP0104032A3 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
AU4833897A (en) Glial mitogenic factors, their preparation and use
SG141233A1 (en) Control of gene expression
MX9705039A (es) Genes y proteinas de muerte celular programada.
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
AU2077197A (en) Polypeptides having phytase activity and nucleic acids encoding same
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
MX9702212A (es) Proteinas plaguicidas novedosas y cepas.
AU5155996A (en) Control of pod dehiscence
WO1998051663A3 (en) 3-epi compounds of vitamin d3 and uses thereof
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
IL142761A0 (en) Novel system for regulating transgene expression
AU7154096A (en) Blue copper oxidase mutants with enhanced activity
AU1054699A (en) Cold-inducible expression vector
AU1896500A (en) High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
HK1038572A1 (en) Growth differentiation factor promoter and uses therefor
AU3382097A (en) Aspergillus oryzae 5-aminolevulinic acid synthases and nucleic acids encoding same
WO2004033653A3 (en) Gene regulation with aptamer and modulator complexes for gene therapy
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
MX9206265A (es) Procedimiento biosintetico para la preparacion de compuestos quimicos.
EP0808364A4 (en) HUMAN PANCREAS CELL LINES: DEVELOPMENTS AND APPLICATIONS
DE69940267D1 (de) Wirtszellen, die rekombinantes humanes erythropoietin exprimieren
DE69332373D1 (de) Menschlicher epidermaler Gen-Promotor
AU1526099A (en) Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
AU6722498A (en) Disubstituted biphenyloxazolines
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same